Intranasal beclomethasone dipropionate in seasonal rhinitis in general practice
Blair, H.; Butler, A.G.
Practitioner 216(1293): 347-351
1976
ISSN/ISBN: 0032-6518 PMID: 4785 Document Number: 96743
Thirty-five patients with seasonal allergic rhinitis were treated in a double-blind comparative trial in and East London Group Practice with either beclomethasone dipropionate (50 micrograms in each nostril four times a day) or a placebo aerosol preparation identical in appearance. There was a statistically significant difference in favour of intranasal beclomethasone dipropionate (P less than 0-05).